2023-08-14 07:29:28 ET
- Gamida Cell press release ( NASDAQ: GMDA ): Q2 GAAP EPS of -$0.31 misses by $0.11 .
- As of June 30, 2023, Gamida Cell had total cash and cash equivalents of $54.1 million compared to $64.7 million as of December 31, 2022.
- The company expects its current cash and cash equivalents, including the funds raised subsequent to the close of the second quarter, to support its ongoing operating activities into the second quarter of 2024, based on Gamida Cell’s current operational plans and excluding commercialization activities beyond the initial launch of Omisirge, as well as any additional financing activities that may be undertaken.
For further details see:
Gamida Cell GAAP EPS of -$0.31 misses by $0.11